Adjuvant Chemotherapy in p16-Positive OPSCC

This cohort study compares survival between surgically managed patients with p16-positive oropharyngeal squamous cell carcinoma who received adjuvant chemoradiotherapy vs patients who received adjuvant radiotherapy alone.

http://ift.tt/2gHoefI